Global Health Limited has informed the Exchange about Schedule of meet
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Global Health Limited (Medanta) has shared its schedule of upcoming meetings with analysts and institutional investors for September 2025. Five meetings are lined up: one-on-one with Aditya Birla Capital on Sept 4, a UBS-organized investor group meeting on Sept 10, a Citi India Healthcare and Pharma Tour group meeting on Sept 15, a Jefferies-organized investor group meeting on Sept 15, and the Jefferies 4th India Forum on Sept 17 with both one-on-one and group meetings. All meetings are physical and will be held in Gurugram. The company has clarified that no Unpublished Price Sensitive Information (UPSI) will be shared during these interactions, and the schedule is subject to change due to unforeseen circumstances.
This is a routine compliance filing under SEBI disclosure rules and does not carry any material business or financial information. It simply signals active investor engagement, which is standard practice for listed companies and is unlikely to have a direct impact on the stock price.